{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Buena",
      "state": "NJ",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "88145",
      "recalling_firm": "Teligent Pharma, Inc.",
      "address_1": "105 Lincoln Avenue",
      "address_2": "N/A",
      "postal_code": "08310",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-0689-2021",
      "product_description": "Erythromycin Topical Solution USP, 2% 60 mL, Rx Only, Teligent Pharma, Inc.,  Buena, NJ 08310, NDC 52565-027-59",
      "product_quantity": "7872 tubes",
      "reason_for_recall": "Failed Impurities/Degradation Specifications",
      "recall_initiation_date": "20210622",
      "center_classification_date": "20210719",
      "termination_date": "20240703",
      "report_date": "20210728",
      "code_info": "Lot 14180",
      "more_code_info": ""
    }
  ]
}